{"organizations": [], "uuid": "6d98e93468870f61ee05de67ead58291fb796490", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180502.html", "section_title": "Archive News &amp; Video for Wednesday, 02 May 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-h-lundbeck-says-fda-updates-trinte/brief-h-lundbeck-says-fda-updates-trintellix-label-to-include-data-showing-improvement-in-processing-speed-idUSASO00045O", "country": "US", "domain_rank": 408, "title": "BRIEF-H Lundbeck says FDA updates Trintellix label to include data showing improvement in processing speed", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.194, "site_type": "news", "published": "2018-05-03T04:49:00.000+03:00", "replies_count": 0, "uuid": "6d98e93468870f61ee05de67ead58291fb796490"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-h-lundbeck-says-fda-updates-trinte/brief-h-lundbeck-says-fda-updates-trintellix-label-to-include-data-showing-improvement-in-processing-speed-idUSASO00045O", "ord_in_thread": 0, "title": "BRIEF-H Lundbeck says FDA updates Trintellix label to include data showing improvement in processing speed", "locations": [], "entities": {"persons": [{"name": "brief-h lundbeck", "sentiment": "negative"}, {"name": "lundbeck", "sentiment": "negative"}], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "fda", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}, {"name": "mdd", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 2 (Reuters) - H Lundbeck A/S:\n* REG-FDA UPDATES TRINTELLIXÂ® (VORTIOXETINE) LABEL TO INCLUDE DATA SHOWING IMPROVEMENT IN PROCESSING SPEED, AN IMPORTANT ASPECT OF COGNITIVE FUNCTION IN ACUTE MAJOR DEPRESSIVE DISORDER (MDD)\n* U.S. FDA APPROVED A SUPPLEMENTAL NEW DRUG APPLICATION FOR TRINTELLIX (VORTIOXETINE)\n* FOCUS AND CONNECT STUDIES SHOW TRINTELLIX HAS A POSITIVE EFFECT ON PROCESSING SPEED Source text for Eikon: Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-05-03T04:49:00.000+03:00", "crawled": "2018-05-03T12:31:36.041+03:00", "highlightTitle": ""}